A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination | MicrobiomeTrials← Back to trialsNCT06168942
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
SUSPENDEDNAINTERVENTIONAL
Trial Details
Start: 2024-02-19Est. Completion: 2028-12-01
Enrollment target: 1,500 participants Locations- Grandview Medical Center, Birmingham, Alabama, United States
- Arizona Arrhythmia Research Group Phoenix Cardio Research Group PCRG, Phoenix, Arizona, United States
- Tucson Medical Center, Tucson, Arizona, United States
- Arrhythmia Research Group, Jonesboro, Arkansas, United States
- Cedars Sinai Medical Center, Los Angeles, California, United States
- Stanford Health Care, Palo Alto, California, United States
- Univeristy of California Davis Health, Rancho Cordova, California, United States
- Scripps Health, San Diego, California, United States
- Providence Saint John's Health Center and the Pacific Heart Institute, Santa Monica, California, United States
- Los Robles Regional Medical Center, Thousand Oaks, California, United States
- NCH Healthcare, North Naples, Florida, United States
- Sarasota Memorial Hospital, Sarasota, Florida, United States
- Piedmont Healthcare, Atlanta, Georgia, United States
- Emory University, Atlanta, Georgia, United States
- Memorial Health University Medical Center, Savannah, Georgia, United States
Other microbiome trials you might be interested in
Cardiometabolic Diseases
Our objective is to create a cardiometabolic cohort that could be representative of the local population, consisting of …
Doha, QatarEst. completion Dec 30, 2036
Atrial Fibrillation
Atrial fibrillation (AF) is fairly prevalent in patients with end stage renal disease (ESRD) with the prevalence estimat…
Shatin, Hong KongCompleted Dec 31, 2025
The Kansas City Heart Rhythm Institute, Overland Park, Kansas, United StatesAscension via Christi Hospitals Wichita Inc, Wichita, Kansas, United StatesBaptist Health Lexington, Lexington, Kentucky, United StatesMassachusetts General Hospital, Boston, Massachusetts, United StatesNorthwell Health, Bay Shore, New York, United StatesNYU Langone Health, New York, New York, United StatesIcahn School of Medicine at Mount Sinai, New York, New York, United StatesColumbia University in the City of New York and The New York and Presbyterian Hospital, New York, New York, United StatesMontefiore Medical Center, The Bronx, New York, United StatesWake Forest University Health Sciences, Charlotte, North Carolina, United StatesBethesda North Hospital Trihealth, Cincinnati, Ohio, United StatesLindner Clinical Trial Center/Christ Hospital, Cincinnati, Ohio, United StatesOhio State University, Columbus, Ohio, United StatesOhio Health, Columbus, Ohio, United StatesTrident Medical Center, North Charleston, South Carolina, United StatesCentennial Medical Center, Nashville, Tennessee, United StatesVanderbilt University Medical Center, Nashville, Tennessee, United StatesTexas Cardiac Arrhythmia Research Foundation, Austin, Texas, United StatesHeart Rhythm Associates, Shenandoah, Texas, United StatesSwedish Medical Center, Seattle, Washington, United StatesSt Joseph Hospital and Medical Center, Tacoma, Washington, United StatesAtrial Fibrillation (AF)
Ischemia Stroke
This prospective, multicenter, randomized, open-label, blinded-endpoint trial aims to evaluate the efficacy and safety o…
Hangzhou, ChinaEst. completion Nov 1, 2031